Amgen Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
7.2
Buy
Overall
6.3
Hold
Quality
Health
Growth
Valuation
Sentiment
AMGN
High-quality business with 106% return on equity and 21% profit margins.
⚠ high leverage at 6.4× debt-to-equity.
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
HOLD
Target $352.73 (+1.2%)
30 analysts
BUY
Target $387.27 (+5.1%)
26 analysts
Fundamentals
AMGN
UNH
24.5×
Trailing P/E
27.8×
14.9×
Forward P/E
17.8×
21.0%
Profit Margin
2.7%
70.8%
Gross Margin
18.8%
106.1%
ROE
12.2%
8.6%
Revenue Growth
2.0%
112.1%
Earnings Growth
0.7%
0.47
Beta
0.41
—
Price / Book
—
$187.9B
Market Cap
$334.6B
$261 – $391
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.